Vault-13

Syncona Portfolio Ltd

St Peter Port, Guernsey, X0 · CIK 1725042 · 13F filing filed 2022-08-10

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$70.4m reported value -32.8% vs Q1 2022
4positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ACHILLES THERAPEUTICS PLC SPONSORED ADS SPONSORED ADS 11,086,909 $27.9m39.70% 39.70% UnchangedShares held: Q3 2021 —, Q4 2021 11.1m, Q1 2022 11.1m, Q2 2022 11.1m
2 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 7,346,829 $20.8m29.54% 29.54% UnchangedShares held: Q3 2021 —, Q4 2021 7.3m, Q1 2022 7.3m, Q2 2022 7.3m
3 FREELINE THERAPEUTICS HLDGS SPONSORED ADS SPONSORED ADS 21,997,620 $19.3m27.43% 27.43% UnchangedShares held: Q3 2021 —, Q4 2021 3.0m, Q1 2022 22.0m, Q2 2022 22.0m
4 ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAPY ADAPY 1,377,294 $2.3m3.33% 3.33% UnchangedShares held: Q3 2021 —, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
AUTOLUS THERAPEUTICS PLC AUTL · 13G · filed 2025-05-07 AUTL 10.8% 13G 2025-05-07